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of applied radioactivity is appropriate. In raising this concern, what 
Vahlquist and Torma failed to keep in mind is that the kinetics of 
uptake of free [3H]retinol or [3H]retinol from RBP are concentration 
independent (Figs 5 and 6). Therefore, although the absolute amount 
of retinol taken up by the cells is obviously concentration depen-
dent, the kinetics of uptake are not. Thus, the curves illustrated in 
Figs 1 and 2 would remain unchanged if we had simply added 
unlabeled retinol to those incubations containing free [3H]retinol, 
so that the final concentration of retinol was identical to that found 
in the incubations containing [3H]retinol-RBP complex. While 
Vahlquist and Torma prefer to interpret the observed linear kinetics 
of uptake of [3H]retinol from RBP as a "receptor mechanism oper-
ating at non-saturating conditions," this mechanism can be ruled 
out because we failed to observe significant inhibition of [3H]retinol 
uptake from RBP by excess unlabeled holoRBP at concentrations as 
high as those found in serum (50 Ilg/ml, Fig 6). 
We agree with the third point raised by Vahlquist and Torma that 
our findings that free retinol and retinol delivered bound to RBP are 
equipotent in the three biologic responses we measured (Figs 7 -9) 
does not prove that retinol enters the cells via the aqueous phase. The 
experiments were, in fact, never envisioned to prove that point. 
However, we reasoned that retinol delivered from RBP would be 
more potent if an RBP receptor system was operative, because it 
would be delivered in a precise way to the plasma membrane that 
could then enhance its subsequent metabolism to retinoic acid. 
However, no difference in potency was found. In addition, recent 
results have shown that the metabolism of [3H]retinol delivered to 
HKc either free or bound to RBP is the same (J.R. Hodam and K.E. 
Creek, unpublished results). The comment that our results on mod-
ulation of keratin expression are at variance with preliminary unpub-
lished results of c.-o. Bivik and U. Eriksson is irrelevant. First, the 
results reported by Hodam et al [1] are not preliminary but have 
been repeated many times. In addition, the conditions we used 
for the culture of HKc must be very different than those used by 
Bavik and Eriksson because our cells do not express keratin Kl 
(Fig 9). 
In conclusion, we feel that our data strongly support RBP recep-
tor-independent delivery of retinol to HKc. We, of course, cannot 
rule out the possibility that an RBP receptor system may function in 
other cell types, such as RPE cells [9]. However, we have also failed 
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to detect binding of 125I-Iabeled RBP to cultured human RPE cells 
(R. Hunt and K. E. Creek, unpublished results). 
KimE. Creek 
John R. Hodam 
Phaedria St. Hilaire 
Department of Chemistry and Biochemis~ry 
University of South Caroltna 
Columbia, South Carolina, U.S.A. 
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Epidermal Interleukin lex Functional Activity and Interleukin 8 
Immunoreactivity Are Increased in Patients with Cutaneous T-Cell Lymphoma 
To the Editor: 
In their recent paper [1], Hansen et al have claimed that epidermal 
interleukin 1 (IL-l) ex functional activity is increased in cutaneous 
T-cell lymphoma (CTCL). This implies that the authors have di-
rectly measured IL-l biologic activity in lesional and control epi-
dermal samples. A closer look at their data shows that they have 
obtained epidermal cell suspensions from the roofs of suction blis-
ters, have cultured these in serum-containing medium for 48 h, 
then measured IL-lex and IL-1P levels in culture supernatants by 
enzyme-linked immunosorbent assay (ELISA). In this protocol, 
higher IL-lex immunoreactivity was present in samples from CTCL 
lesions than normal controls. This data is not the result of the direct 
measurement of IL-l in epidermal samples, and we believe caution 
should be exercised in extrapolating it to the in vivo state, especially 
as the authors' immunohistochemical data seemed to show little 
difference in staining between lesional and control samples. Further-
more, the authors have only bioassayed CTCL culture supernatants, 
thereby confirming the presence of IL-l biologic activity. They 
have not reported the results of quantitative bioassays, nor compared 
activity in CTCL and control supernatants. Their claim that epider-
malIL-lex functional activity is increased in CTCL must therefore be 
held open to question. 
We wish to refer the authors to our/revious work, which they 
have not cited and which was publishe in the dermatologic litera-
ture some months before the submission date of their manuscript 
[2]. In this work we sampled mycosis fungo ides (MF) lesions and 
clinically uninvolved skin by using a chamber method, and mea-
sured IL-l activity directly in these samples by a specific bioassay. 
IL-l activity in lesional samples was significantly lower than in con-
trols, a finding which, interestingly, matches what has been shown 
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in psoriasis. The past work on IL-l in CTCL was reviewed in our 
article, and its possible status in the pathogenesis oflesionallympho-
cyte infiltrates in MF discussed [2]. We were only able to conclude 
that the role ofIL-l in MF lesions is uncertain. If the lower levels of 
activity in lesional samples result from increased release of pre-
formed IL-l, then this cytokine may be pathogenically relevant. 
Frances Lawlor 
Richard Camp 
Malcolm Greaves 
St John's Institute of Dermatology 
St Thomas's Hospital 
London, U.K. 
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REPLY 
We appreciate the comment of Lawlor et al on our results regarding 
IL-1a and IL-1P measurement in epidermal cell culture superna-
tants obtained from both normal and lesional CTCL skin [1]. Using 
enzyme-linked immunosorbent assay (ELISA) kits, we found a sig-
nificant but small increase of IL-1a protein release, but not IL-1P, 
from cultured lesional CTCL epidermal cells compared to cultured 
normal epidermal cells. In the t~ymo~yte-prol~feration assay, the 
IL-la protein was found to be bIOlogically actl~e. Because IL-la 
protein was increased and because the IL-1a protem was found to be 
active we concluded that IL-la activity was increased. Lawlor et al 
emphasize the importance of quantitative bioassays. However, such 
assays may not reveal the actual IL-l activity due to the presence of 
IL-l inhibitors that mask IL-l functional activity. 
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It can be argued that measurements of IL-l in epidermal cell 
culture supernatants do not reflect the in vivo situation. We agree 
with this statement; however, we did stress both in the abstract as 
well as in the Materials and Methods and R esult section that our data 
reflect in vitro analysis. Furthermore, the lack of enhanced immuno-
reactivity in situ is not surprising because the ELISA technique is 
more sensitive when small changes have to be detected. 
The investigations performed by Lawlor et al used techniques by 
which an undefined part of the epidermis was removed by a scalpel 
[2] . The IL-l they assayed may in addition to the epidermal cells 
originate from fibroblasts , endothelial cells, and macrophages, as 
well as transudate from the vascular system. Therefore comparison 
of their results with ours is not possible. Neither do we think they 
can compare their result to Dr. Kevin Cooper's finding of decreased 
IL-la in psoriasis because homogenized keratome extracts and not 
skin chamber fluid was assayed in that study [3]. 
Erik R. Hansen 
Gunhild Vejlsgaard 
Steen Lisby 
Michael Heidenheim 
Ole Baadsgaard 
Departments of Dermatology 
Gentofte Hospital and Rigshospitalet 
University of Copenhagen 
Copenhagen, Denmark 
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Expression of Simple Epithelial Keratins in Epidermal Neoplasia Is Not 
Directly and Exclusively Related to Malignancy 
To the Editor: 
We read with great interest the paller by Markey et al in the N 0-
vember 1991 issue of the J oumal [1 J. Using a large panel of mono-
specific monoclonal antibodies against individual keratins, the au-
thors confirmed and extended previous reports on the expression of 
simple epithelial cytokeratin in pre-malignant (actinic keratosis), in 
situ malignant (Bowen's disease), and invasive malignant (squa-
mous cell carcinoma) skin lesions [2 - 5] . 
In their conclusion, Markey et al strongly favor a potential corre-
lation between de-differentiation of cytokeratin expression and the 
development of malignancy in keratinocytes. They furthermore 
suggest that "the aberrant expression of simple epithelial keratins 
may be an early marker for the genetic and epigenetic events that 
render keratinocytes capable of invasion." 
We would like to reconsider this conclusion in the presence of 
recent data on the cytokeratin expression in a benign epidermal 
tumor (seborrheic keratosis) [6], which are as follows. 1) A partial 
lack of cytokeratins K1 and K10, revealing a heterogeneous staining 
pattern of suprabasal keratinocytes (n = 10/10).2) K5-positive cells 
in suprabasal layers (n = 5/10). 3) A novel expression of simple 
epithelial cytokeratins (K8, K18, or K19, respectively, n = 8/10). 
4) The absence of ultrastructural characteristics of cells known to 
express simple epithelial keratins (such as sweat gland cells or Mer-
kel cells) in K-19 immunoreactive tumor cells. 
Based on these data we conclude that de-differentiation (or re-
differentiation towards embryonic keratinocytes?) of keratinocytes 
in terms of simple epithelial cytokeratin expression is not directly 
and exclusively related to malignant growth. But, in agreement 
with the authors' alternative hypothesis [1], it may suggest the im-
portance of mesenchymal factors in the regulation of cytokeratin-
